title: Alterations of bile acid composition in gallstones, bile, and liver of patients with hepatolithiasis, and their etiological significance.
abstract: A detailed comparison was made of the bile acid composition in gallstones (brown pigment stones) and paired bile and liver from both affected and unaffected lobes by gallstones, which were taken at operation from 16 patients with hepatolithiasis, with the aim of elucidating whether stone formation is derived from possible local disturbances limited to intrahepatic bile ducts. Brown pigment stones in the intrahepatic bile ducts, most of which were accompanied by bile with high cholesterol saturation, had significantly more cholesterol, and less calcium bilirubinate and bile acid than those found in the extrahepatic bile ducts. Intrahepatic gallstones had significantly lower amounts of secondary and unconjugated bile acids, the bile acids modified by bacterial intervention, than extrahepatic stones. Bile specimens from both affected and unaffected lobes showed significantly increased molar percentages of cholesterol and decreased percentages of bile acids than bile from controls. In contrast, liver specimens from both lobes showed significantly higher concentrations of total bile acids. Secondary bile acids were present in a much lower proportion in bile and liver from both lobes than in bile and liver from controls. On the other hand, unconjugated bile acids were present in a much higher proportion in bile and liver from patients and only in negligible amounts in bile from controls. Furthermore, the plasma levels of mevalonate and those of 7 alpha-hydroxy-4-cholestene-3-one were found to be significantly higher and lower in patients than in controls, respectively, indicating that in hepatolithiasis cholesterol synthesis might increase and bile acid synthesis might decrease in the liver. These findings suggested that alterations of bile acid composition in gallstones, bile, and liver of patients with hepatolithiasis may be attributed to not only secondary changes resulting from local disturbances limited to intrahepatic bile ducts but also possible primary alterations of hepatocyte metabolism, such as bile acid conjugation and primary defects in cholesterol and bile acid synthesis.
authors.affiliation: Department of Gastroenterology and Hepatology, University of Tsukuba School of Medicine, Ibaraki, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Shoda
authors.forename: N
authors.initials: N
authors.lastname: Tanaka
authors.forename: B F
authors.initials: BF
authors.lastname: He
authors.forename: Y
authors.initials: Y
authors.lastname: Matsuzaki
authors.forename: T
authors.initials: T
authors.lastname: Osuga
authors.forename: H
authors.initials: H
authors.lastname: Miyazaki
mesh_terms: D001646:Bile / Q000737:chemistry*; D001647:Bile Acids and Salts / Q000032:analysis*; D001649:Bile Duct Diseases / Q000209:etiology / Q000378:metabolism; D001653:Bile Ducts, Intrahepatic / Q000378:metabolism*; D002769:Cholelithiasis / Q000737:chemistry* / Q000209:etiology; D002783:Cholestenones / Q000097:blood; D002784:Cholesterol / Q000032:analysis; D005260:Female; D006801:Humans; D008099:Liver / Q000737:chemistry* / Q000378:metabolism; D008297:Male; D008798:Mevalonic Acid / Q000097:blood; D010743:Phospholipids / Q000032:analysis
chemical_list: D001647:Bile Acids and Salts; D002783:Cholestenones; D010743:Phospholipids; C002656:7 alpha-hydroxy-4-cholesten-3-one; D002784:Cholesterol; D008798:Mevalonic Acid